Erratum: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (Antimicrobrial Agents and Chemotherapy (2001) 45:11 (3122-3127))
Hoofdauteurs: | Imwong, M, Pukrittayakamee, S, Looareesuwan, S, Pasvol, G, Poirriez, J, White, N, Snounou, G |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2002
|
Gelijkaardige items
-
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
door: Imwong, M, et al.
Gepubliceerd in: (2002) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
door: Imwong, M, et al.
Gepubliceerd in: (2001) -
Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker.
door: Imwong, M, et al.
Gepubliceerd in: (2001) -
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
door: Peto, T, et al.
Gepubliceerd in: (1985) -
Sulfadoxine-pyrimethamine for the treatment of malaria.
door: White, N
Gepubliceerd in: (1991)